Clinical Trial

CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 20 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years prior, with a history of tremors following transplantation.
Protocol Amendment History 19 amendments
This ClinicalTrials.gov record has been amended 19 times since 2018-12-05; most recent amendment 2026-04-07.
Status change: Suspended → Recruiting 2020-07-06
Status change: Recruiting → Suspended 2020-03-25
Status change: Not Yet Recruiting → Recruiting 2019-02-01
Trial Details
NCT Number NCT03769298
Lead Sponsor University of Wisconsin, Madison
Collaborators: Veloxis Pharmaceuticals
Conditions Kidney Pancreas Transplantation
Enrollment 20 participants
Start Date 2019-02-27
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-13